Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the COPD and systemic consequences-comorbidities network study

American Journal of Respiratory and Critical Care Medicine

Volumn 195, Issue 2, 2017, Pages 189-197

  Houben Wilke, Sarah ^a   Jörres, Rudolf A ^b   Bals, Robert ^c   Franssen, Frits M E ^a,d   Gläser, Sven ^e   Holle, Rolf ^f   Karch, Annika ^g   Koch, Armin ^g   Magnussen, Helgo ^h   Obst, Anne ^e   Schulz, Holger ^f   Spruit, Martijn A ^a,i   Wacker, Margarethe E ^f   Welte, Tobias ^g   Wouters, Emiel F M ^a,d   Vogelmeier, Claus ^j   Watz, Henrik ^h  

^a Ciro   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h Member of the German Center for Lung Research   (Germany)

ⁱ HASSELT UNIVERSITY   (Belgium)

^j UNIVERSITY HOSPITAL MARBURG   (Germany)

more..

Author keywords

Chronic obstructive pulmonary disease; Comorbidities; Functional capacity; Health status; Peripheral vascular disease

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; VISUAL ANALOG SCALE; CLINICAL TRIAL; COMORBIDITY; COMPLICATION; DAILY LIFE ACTIVITY; HEALTH STATUS; LONGITUDINAL STUDY; MULTICENTER STUDY; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ACTIVITIES OF DAILY LIVING; AGED; ANKLE BRACHIAL INDEX; COMORBIDITY; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85009773793     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201602-0354OC     Document Type: Article

References (49)

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
2. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:728-735.
3. Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med 2012;12:26.
4. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185.
5. Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest 2013;144:1163-1178.
6. Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, Laffaye N, Fuselli JJ, Massolin HP, Gambarte J, et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012;39: 51-58.
7. Sibila O, Mortensen EM, Anzueto A, Laserna E, Restrepo MI. Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia. Eur Respir J 2014;43:36-42.
8. Gillum RF. Peripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality. Am Heart J 1990;120: 1414-1418.
9. Dhaliwal G, Mukherjee D. Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment. Int J Angiol 2007;16:36-44.
10. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FG, Hiatt WR, Jönsson B, Lacroix P, et al.; American Heart Association Council on Peripheral Vascular Disease; Council on Epidemiology and Prevention; Council on Clinical Cardiology; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012;126:2890-2909.
11. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, et al.; Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208.
12. Watz H, Wilke S, Bals R, Karch A, Koch A, Schulz H, Welte T, Vogelmeier C, Jörres R. Prevalence of peripheral artery disease in patients with chronic obstructive pulmonary disease: results of the COSYCONET study [abstract]. Am J Respir Crit Care Med 2015;191: A5710.
13. Wilke S,Watz H, Bals R, Franssen F, Holle R, Karch A, Koch A, Schulz H, Spruit M, Wacker ME, et al. Impact of peripheral artery disease on functional capacity and health status in patients with chronic obstructive pulmonary disease: results of the COSYCONET study [abstract]. Am J Respir Crit Care Med 2015;191:A6204.
14. Wilke S, Bals R, Franssen F, Karch K, Koch A, Schulz H, Spruit MA, Welte T, Wouters E, Jörres R, et al. Impact of peripheral artery disease on functional capacity in patients with COPD: results of the COSYCONET study [abstract]. Eur Respir J 2015;46:PA2069.
15. Karch A, Vogelmeier C, Welte T, Bals R, Kauczor HU, Biederer J, Heinrich J, Schulz H, Gläser S, Holle R, et al.; COSYCONET Study Group. The German COPD cohort COSYCONET: aims, methods and descriptive analysis of the study population at baseline. Respir Med 2016;114:27-37.
16. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
17. Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, et al. Cohort profile: the Study of Health in Pomerania. Int J Epidemiol 2011;40:294-307.
18. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-1343.
19. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 1993;6:41-52.
20. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR III, Friedman L, Fuster V, Herrington DM, et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000;101: E16-E22.
21. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
22. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1428-1446.
23. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14:270-274.
24. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327.
25. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-654.
26. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005; 2:75-79.
27. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2014;2:195-203.
28. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005;6:124-130.
29. Zanini A, Aiello M, Adamo D, Casale S, Cherubino F, Della Patrona S, Raimondi E, Zampogna E, Chetta A, Spanevello A. Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respir Care 2015;60:88-95.
30. Kim SK, Kim SH, Jo MW, Lee SI. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke. Health Qual Life Outcomes 2015;13:32.
31. Kwakkenbos L, Fransen J, Vonk MC, Becker ES, Jeurissen M, van den Hoogen FH, van den Ende CH. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis. Clin Exp Rheumatol 2013;31(2 suppl 76):50-56.
32. Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007;5:70.
33. Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Koch A, Schulz H, Watz H, Leidl R, et al.; COSYCONET-Consortium. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med 2016;16:70.
34. Lin MS, Hsu KY, Chen YJ, Chen CR, Chen CM, Chen W. Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan. PLoS One 2013;8:e64714.
35. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177:743-751.
36. Blum A, Simsolo C, Sirchan R, Haiek S. "Obesity paradox" in chronic obstructive pulmonary disease. Isr Med Assoc J 2011;13:672-675.
37. Pecci R, De La Fuente Aguado J, Sanjurjo Rivo AB, Sanchez Conde P, Corbacho Abelaira M. Peripheral arterial disease in patients with chronic obstructive pulmonary disease. Int Angiol 2012;31:444-453.
38. Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 2015;3:631-639.
39. Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, Brusselle GG, Ikram MA. Chronic obstructive pulmonary disease and the risk of stroke: the Rotterdam Study. Am J Respir Crit Care Med 2016;193:251-258.
40. O'Hare PE, Ayres JF, O'Rourke RL, Slaughter RE, Marshall HM, Bowman RV, Fong KM, Yang IA. Coronary artery calcification on computed tomography correlates with mortality in chronic obstructive pulmonary disease. J Comput Assist Tomogr 2014;38: 753-759.
41. Castagna O, Boussuges A, Nussbaum E, Marqueste L, Brisswalter J. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil 2008;15:270-277.
42. Sun KS, Lin MS, Chen YJ, Chen YY, Chen SC, Chen W. Is asymptomatic peripheral arterial disease associated with walking endurance in patients with COPD? Int J Chron Obstruct Pulmon Dis 2015;10:1487-1492.
43. McDermott MM, Guralnik JM, Ferrucci L, Tian L, Liu K, Liao Y, Green D, Sufit R, Hoff F, Nishida T, et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation 2008;117: 2484-2491.
44. Wilke S, Spruit MA, Wouters EF, Schols JM, Franssen FM, Janssen DJ. Determinants of 1-year changes in disease-specific health status in patients with advanced chronic obstructive pulmonary disease: a 1-year observational study. Int J Nurs Pract 2015;21:239-248.
45. Dürr S, Zogg S, Miedinger D, Steveling EH, Maier S, Leuppi JD. Daily physical activity, functional capacity and quality of life in patients with COPD. COPD 2014;11:689-696.
46. Maksimovic M, Vlajinac H, Marinkovic J, Kocev N, Voskresenski T, Radak D. Health-related quality of life among patients with peripheral arterial disease. Angiology 2014;65:501-506.
47. Wilke S, Janssen DJ, Wouters EF, Schols JM, Franssen FM, Spruit MA. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study. Health Qual Life Outcomes 2012;10:98.
48. Frei A, Muggensturm P, Putcha N, Siebeling L, Zoller M, Boyd CM, ter Riet G, Puhan MA. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol 2014;67:904-911.
49. Aronow WS. Usefulness of the ankle-brachial index. Angiology 2014; 2:e106.